Report Detail
Global (United States, European Union and China) Angiogenesis Modulators Market Research Report 2019-2025
- RnM3348660 |
- 23 April, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Angiogenesis Modulators is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Angiogenesis Modulators.
This report studies the global market size of Angiogenesis Modulators, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Angiogenesis Modulators sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Celgene Corporation (USA)
Eisai Co., Ltd. (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)
Market Segment by Product Type
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others
Market Segment by Application
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Angiogenesis Modulators status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Angiogenesis Modulators manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Angiogenesis Modulators are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Angiogenesis Modulators Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Angiogenesis Inhibitors
- 1.3.3 Angiogenesis Stimulators
- 1.3.4 Angiogenin
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Angiogenesis Modulators Market Share by Application (2019-2025)
- 1.4.2 Breast Cancer
- 1.4.3 Colorectal Cancer
- 1.4.4 Lung Cancer
- 1.4.5 Prostate Cancer
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Angiogenesis Modulators Market Size
- 2.1.1 Global Angiogenesis Modulators Revenue 2014-2025
- 2.1.2 Global Angiogenesis Modulators Sales 2014-2025
- 2.2 Angiogenesis Modulators Growth Rate by Regions
- 2.2.1 Global Angiogenesis Modulators Sales by Regions 2014-2019
- 2.2.2 Global Angiogenesis Modulators Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Angiogenesis Modulators Sales by Manufacturers
- 3.1.1 Angiogenesis Modulators Sales by Manufacturers 2014-2019
- 3.1.2 Angiogenesis Modulators Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Angiogenesis Modulators Revenue by Manufacturers (2014-2019)
- 3.2.2 Angiogenesis Modulators Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Angiogenesis Modulators Market Concentration Ratio (CR5 and HHI)
- 3.3 Angiogenesis Modulators Price by Manufacturers
- 3.4 Key Manufacturers Angiogenesis Modulators Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Angiogenesis Modulators Market
- 3.6 Key Manufacturers Angiogenesis Modulators Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Angiogenesis Inhibitors Sales and Revenue (2014-2019)
- 4.1.2 Angiogenesis Stimulators Sales and Revenue (2014-2019)
- 4.1.3 Angiogenin Sales and Revenue (2014-2019)
- 4.1.4 Others Sales and Revenue (2014-2019)
- 4.2 Global Angiogenesis Modulators Sales Market Share by Type
- 4.3 Global Angiogenesis Modulators Revenue Market Share by Type
- 4.4 Angiogenesis Modulators Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Angiogenesis Modulators Sales by Application
6 United States
- 6.1 United States Angiogenesis Modulators Breakdown Data by Company
- 6.2 United States Angiogenesis Modulators Breakdown Data by Type
- 6.3 United States Angiogenesis Modulators Breakdown Data by Application
7 European Union
- 7.1 European Union Angiogenesis Modulators Breakdown Data by Company
- 7.2 European Union Angiogenesis Modulators Breakdown Data by Type
- 7.3 European Union Angiogenesis Modulators Breakdown Data by Application
8 China
- 8.1 China Angiogenesis Modulators Breakdown Data by Company
- 8.2 China Angiogenesis Modulators Breakdown Data by Type
- 8.3 China Angiogenesis Modulators Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Angiogenesis Modulators Breakdown Data by Company
- 9.2 Rest of World Angiogenesis Modulators Breakdown Data by Type
- 9.3 Rest of World Angiogenesis Modulators Breakdown Data by Application
- 9.4 Rest of World Angiogenesis Modulators Breakdown Data by Countries
- 9.4.1 Rest of World Angiogenesis Modulators Sales by Countries
- 9.4.2 Rest of World Angiogenesis Modulators Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Celgene Corporation (USA)
- 10.1.1 Celgene Corporation (USA) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.1.4 Angiogenesis Modulators Product Introduction
- 10.1.5 Celgene Corporation (USA) Recent Development
- 10.2 Eisai Co., Ltd. (Japan)
- 10.2.1 Eisai Co., Ltd. (Japan) Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.2.4 Angiogenesis Modulators Product Introduction
- 10.2.5 Eisai Co., Ltd. (Japan) Recent Development
- 10.3 Amgen, Inc. (USA)
- 10.3.1 Amgen, Inc. (USA) Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.3.4 Angiogenesis Modulators Product Introduction
- 10.3.5 Amgen, Inc. (USA) Recent Development
- 10.4 Genentech, Inc. (USA)
- 10.4.1 Genentech, Inc. (USA) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.4.4 Angiogenesis Modulators Product Introduction
- 10.4.5 Genentech, Inc. (USA) Recent Development
- 10.5 GlaxoSmithKline plc (UK)
- 10.5.1 GlaxoSmithKline plc (UK) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.5.4 Angiogenesis Modulators Product Introduction
- 10.5.5 GlaxoSmithKline plc (UK) Recent Development
- 10.6 Bayer Pharma AG (Germany)
- 10.6.1 Bayer Pharma AG (Germany) Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.6.4 Angiogenesis Modulators Product Introduction
- 10.6.5 Bayer Pharma AG (Germany) Recent Development
- 10.7 Bionomics Ltd. (Australia)
- 10.7.1 Bionomics Ltd. (Australia) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.7.4 Angiogenesis Modulators Product Introduction
- 10.7.5 Bionomics Ltd. (Australia) Recent Development
- 10.8 CASI Pharmaceuticals, Inc. (USA)
- 10.8.1 CASI Pharmaceuticals, Inc. (USA) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.8.4 Angiogenesis Modulators Product Introduction
- 10.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Development
- 10.9 AstraZeneca plc (UK)
- 10.9.1 AstraZeneca plc (UK) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.9.4 Angiogenesis Modulators Product Introduction
- 10.9.5 AstraZeneca plc (UK) Recent Development
- 10.10 Eli Lilly and Company (USA)
- 10.10.1 Eli Lilly and Company (USA) Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Angiogenesis Modulators
- 10.10.4 Angiogenesis Modulators Product Introduction
- 10.10.5 Eli Lilly and Company (USA) Recent Development
- 10.11 F.Hoffmann-La Roche AG (Switzerland)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Angiogenesis Modulators Sales Channels
- 11.2.2 Angiogenesis Modulators Distributors
- 11.3 Angiogenesis Modulators Customers
12 Market Forecast
- 12.1 Global Angiogenesis Modulators Sales and Revenue Forecast 2019-2025
- 12.2 Global Angiogenesis Modulators Sales Forecast by Type
- 12.3 Global Angiogenesis Modulators Sales Forecast by Application
- 12.4 Angiogenesis Modulators Forecast by Regions
- 12.4.1 Global Angiogenesis Modulators Sales Forecast by Regions 2019-2025
- 12.4.2 Global Angiogenesis Modulators Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Angiogenesis Modulators. Industry analysis & Market Report on Angiogenesis Modulators is a syndicated market report, published as Global (United States, European Union and China) Angiogenesis Modulators Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Angiogenesis Modulators market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
